✉news ScienceBiology first seen 6 d ago, last 5 d ago, peak #2
XPRIZE founder Diamandis launches fund backing Colossal Biosciences
Original: XPRIZE founder Diamandis launches NeoGenesis Capital to back Colossal's programmable biology
Peter Diamandis, founder of the XPRIZE Foundation, has launched NeoGenesis Capital, a new venture firm created to invest in Colossal Biosciences and its work on programmable biology. Colossal, known for its de-extinction projects such as the woolly mammoth, aims to engineer biological systems using genetic tools. The move signals growing investor interest in synthetic biology.
Why now: High-profile venture backing for Colossal's controversial de-extinction and genetic engineering work is drawing attention.
Peter DiamandisNeoGenesis CapitalColossal BiosciencesXPRIZE Foundation
Rank over time, top of the chart is #1. 17 snapshots from 6 d ago to 5 d ago.
Evidence
- XPRIZE founder Diamandis launches NeoGenesis Capital to back Colossal's programmable biology · Dealroom
API: https://socialmediatrends-api.osmike.com/v1/trends/2607888